Medicare Pays for the Mammogram, Not the Second Look

Medicare covers an annual screening mammogram at no cost to the patient, but a callback for additional imaging is billed as diagnostic care, exposing the patient to Part B coinsurance and the annual deductible even when the result comes back clean.

The word "free" does a lot of work in Medicare marketing, and almost none of it survives contact with a callback letter. A screening mammogram — the routine annual exam ordered for a woman with no symptoms and no lump — carries no cost-sharing. The moment a radiologist sees something worth another look, the same body part, the same machine and often the same technologist produce a bill.

The case described by 24/7 Wall St follows a pattern that repeats in clinics every week. A patient went in for her annual mammogram and left relieved. Two weeks later came a phone call asking her to return. She did, the follow-up imaging was clean, and she went home reassured. Then the statement arrived — for a service she had been told cost nothing.

Where the coverage line actually falls

Medicare does not classify imaging by what part of the body is scanned. It classifies by why the scan was ordered. That single distinction is what separates a zero-dollar visit from a billed procedure.

Screening mammography is preventive. It is performed on a patient with no known problem, on a schedule, to look for something no one has yet found. Under Part B, preventive screening mammography is covered without patient cost-sharing.
Diagnostic mammography is investigative. It is ordered because something has already been flagged — a shadow on a prior film, dense tissue that obscured the view, a palpable finding, a physician's concern. Diagnostic imaging sits in the ordinary Part B benefit, which means the annual Part B deductible and Part B coinsurance apply.

A callback is, by definition, the second category. The radiologist has seen something. The new order says so. The billing code changes accordingly, and the patient's obligation changes with it. Crucially, the eventual result does not reverse that. A clean second look is still a diagnostic study. Reassurance is not a billing category.

Add-on imaging tightens the squeeze. If the callback involves additional views, a spot compression film, tomosynthesis or a diagnostic ultrasound of the same area, each service can generate its own line item — and each sits on the diagnostic side of the ledger. A patient who has not yet met the Part B deductible for the year can end up paying the full allowed amount for the follow-up, then coinsurance on anything after that.

Why nobody warns the patient in advance

The failure here is structural rather than malicious. The clinic scheduling the callback is focused on getting the patient back in quickly, which is clinically correct — delay is the real danger with breast imaging. The staff member on the phone is rarely the person who knows how the visit will be coded. And the patient has just been told there is a spot that needs another look, which is not the moment most people think to ask about coinsurance.

The messaging around preventive care compounds it. Public health campaigns emphasize that screening is free, because getting people through the door is the point. That message is accurate and it saves lives. It also leaves a boundary unmarked, and patients only discover the boundary by crossing it.

There is a second layer for anyone in a Medicare Advantage plan rather than original Medicare. Advantage plans must cover the preventive screening at no cost, but cost-sharing on diagnostic follow-up is set by the plan — a copay per imaging service, a facility charge, or in-network rules that a hospital-based imaging suite may or may not satisfy. Two women called back the same week, from the same clinic, can owe different amounts.

What a patient can actually do about it

The leverage is small but real, and most of it exists before the appointment rather than after the bill.

Ask how the visit will be coded when the callback is scheduled. The useful question is not "is this covered" but "is this being billed as screening or diagnostic." The answer tells you whether cost-sharing applies.
Ask where the study will be performed. A hospital outpatient department can generate a facility fee on top of the professional charge; a freestanding imaging center often does not. Same images, different bill.
Check whether the deductible is already met. The dollar exposure on a diagnostic mammogram is very different in January than in November for someone who has already had other Part B care during the year.
Do not skip the callback over cost. Recall rates are high relative to the number of cancers found, which means most callbacks end where this one did — with a clean result. The financial risk of going is a bill. The risk of not going is not financial.
Read the statement against the order. If the follow-up was truly a repeat screening — an unreadable image, a technical failure, a positioning problem rather than a suspicious finding — the coding may be wrong, and a corrected claim is worth asking for.

A cost the market never prices

Household exposure of this kind rarely registers as an economic event. Equity benchmarks closed slightly lower on their most recent session before this story ran, with the S&P 500 tracker at $776.34, down 0.20% on the day, the Nasdaq 100 fund at $731.07 and the Dow tracker at $536.80, as of the last trade at 20:00 GMT on 14 August 2026. None of that moves because a retiree opened a surprise imaging bill.

But the aggregate matters to anyone budgeting a fixed retirement income. Medicare's coverage design pays for the question and charges for the answer, and that structure recurs well beyond breast imaging — a screening colonoscopy that becomes therapeutic when a polyp is removed, a preventive visit that turns into an evaluation once a symptom is mentioned. The lesson generalizes: preventive benefits are defined by intent, and intent can change mid-appointment. The patient is the last to be told and the first to be billed.

Worth watching is whether coverage rules for diagnostic follow-up after an abnormal screen get revisited, as several states have already done for commercial plans. Until then, the practical defense is a single question asked at the scheduling desk.

Key facts

Screening mammogram: Covered by Medicare with no patient cost-sharing
Callback imaging: Coded as diagnostic; Part B deductible and coinsurance apply
Clean result: Does not reverse the diagnostic billing classification
S&P 500 (SPY): $776.34, -0.20%, last trade 20:00 GMT Aug 14, 2026

Frequently asked questions

Why was I billed after a free mammogram?

Because the second visit was almost certainly coded as diagnostic rather than screening. Medicare classifies imaging by the reason it was ordered. A routine annual screen has no cost-sharing. A callback exists because a radiologist flagged something, which places it in the ordinary Part B benefit, where the annual deductible and coinsurance apply.

Does a normal result cancel the bill?

No. The billing classification is set by why the study was ordered, not by what it found. A diagnostic mammogram that shows nothing concerning is still a diagnostic mammogram for coding purposes. Patients frequently assume a clean result converts the visit back to preventive care, and it does not.

What is the difference between screening and diagnostic mammography?

Screening mammography is performed on a schedule for a patient with no known problem, to look for something not yet found. Diagnostic mammography investigates a specific concern — an abnormal prior image, dense tissue that obscured the view, or a palpable finding. Under Medicare, only the screening category is free of patient cost-sharing.

Is it different under Medicare Advantage?

Advantage plans must cover the preventive screening at no cost, but cost-sharing on diagnostic follow-up is set by the individual plan. That can mean a copay per imaging service, a facility charge, or network restrictions that a hospital-based imaging suite may not satisfy. Two patients called back the same week can owe different amounts.

Should I skip a callback to avoid the cost?

No. Most callbacks end with a normal result, but the purpose of the follow-up is to rule out something that imaging has already flagged as worth a second look. The downside of going is a bill. The downside of not going is clinical. Address the cost by asking how the visit will be coded, not by declining it.

What should I ask before the follow-up appointment?

Ask the scheduler whether the study will be billed as screening or diagnostic, and ask where it will be performed — a hospital outpatient department can add a facility fee that a freestanding imaging center does not. Also check whether your Part B deductible has already been met for the year, since that changes your exposure substantially.

Sources

The Screening Mammogram Is Free. The Callback for a ‘Second Look’ Bills Like Any Other Procedure. — 24/7 Wall St

Photo: SHVETS production · Pexels Licence — source